UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000048070
Receipt No. R000054693
Scientific Title Efficacy and safety of Janus kinase 1 inhibitor for chronic pouchitis in patients with ulcerative colitis
Date of disclosure of the study information 2022/07/01
Last modified on 2022/06/16 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Efficacy and safety of filgotinib for refractory pouchitis in patients with ulcerative colitis
Acronym Efficacy of filgotinib for pouchitis
Scientific Title Efficacy and safety of Janus kinase 1 inhibitor for chronic pouchitis in patients with ulcerative colitis
Scientific Title:Acronym Efficacy of Janus kinase 1 inhibitor for pouchitis
Region
Japan

Condition
Condition ulcerative colitis, pouchitis
Classification by specialty
Gastroenterology Gastrointestinal surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Efficacy of filgochinib for pouchitis
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Phase I

Assessment
Primary outcomes imprpvement by using modified pouchitis activity index with treatment.(Evaluations will be performed after 12weeks and 54 weeks of induction.
Key secondary outcomes Incidence and kinds of adverse events during treatment.
Secession from antibiotics use.
Alteration of antibiotics dosage.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Treatment with filgochinib
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria Anti-biotics dependent or refractory pouchitis.
Key exclusion criteria Patients who dose not agree the treatment with filgochinib.
Target sample size 50

Research contact person
Name of lead principal investigator
1st name Hiroki
Middle name
Last name Ikeuchi
Organization Hyogo medical university
Division name Department of Gastroenterological surgery
Zip code 6638501
Address 1-1 Mukogawacho, Nshinomiya city, Hyogo pref
TEL 0798456371
Email ikeuci2s@hyo-med.ac.jp

Public contact
Name of contact person
1st name Motoi
Middle name
Last name Uchino
Organization Hyogo medical university
Division name Department of Gastroenterological surgery
Zip code 6638501
Address 1-1 Mukogawacho, Nshinomiya city, Hyogo pref
TEL 0798456371
Homepage URL
Email uchino2s@hyo-med.ac.jp

Sponsor
Institute Hyogo medical university
Department of Gastroenterological Surgery
Institute
Department

Funding Source
Organization Department of Gastroenterological Surgery,
Hyogo Medical University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Hyogo medical university
Address 1-1 Mukogawacho, Nishinomiya, Hyogo
Tel 0798456371
Email uchino2s@hyo-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 07 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 07 Month 01 Day
Date of IRB
2022 Year 06 Month 30 Day
Anticipated trial start date
2022 Year 07 Month 01 Day
Last follow-up date
2025 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 06 Month 16 Day
Last modified on
2022 Year 06 Month 16 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054693